Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-24 Purchase |
2022-06-28 4:24 pm |
Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks |
2,281 | $1.7539 | $4,000 | 22,281 (Indirect Direct) |
View |
2022-06-14 Purchase |
2022-06-16 7:11 pm |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
15,000 | $1.3897 | $20,846 | 179,662 (Indirect Direct) |
View |
2022-06-13 Purchase |
2022-06-14 4:25 pm |
Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director |
25,000 | $1.4473 | $36,183 | 93,333 (Indirect Direct) |
View |
2022-06-10 Purchase |
2022-06-10 6:23 pm |
Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks |
5,000 | $1.56 | $7,800 | 20,000 (Direct) |
View |
2022-06-09 Purchase |
2022-06-10 4:39 pm |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
25,000 | $1.6542 | $41,355 | 179,662 (Indirect Direct) |
View |
2022-03-31 Purchase |
2022-04-04 4:28 pm |
Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks |
5,000 | $1.98 | $9,900 | 47,800 (Direct) |
View |
2022-03-31 Purchase |
2022-04-04 4:27 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
2,500 | $1.9685 | $4,921 | 2,647,969 (Indirect Direct) |
View |
2022-03-29 Purchase |
2022-03-31 4:39 pm |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
40,000 | $2.1405 | $85,620 | 139,662 (Indirect Direct) |
View |
2022-03-29 Purchase |
2022-03-31 4:38 pm |
Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director |
15,000 | $2.1487 | $32,230 | 68,333 (Indirect Direct) |
View |
2021-12-21 Purchase |
2021-12-23 6:20 pm |
Better Therapeutics Inc. | BTTX | LAVIZZO-MOUREY RISA J Director |
10,000 | $4.6 | $46,000 | 10,000 (Direct) |
View |
2021-12-20 Purchase |
2021-12-22 6:03 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $4.5999 | $4,600 | 2,410,469 (Indirect Direct) |
View |
2021-12-15 Purchase |
2021-12-17 8:43 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
750 | $4.7065 | $3,530 | 2,409,469 (Indirect Direct) |
View |
2021-12-14 Purchase |
2021-12-16 4:32 pm |
Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director |
20,000 | $4.94 | $98,800 | 53,333 (Indirect) |
View |
2021-12-13 Purchase |
2021-12-15 4:53 pm |
Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks |
3,333 | $4.9204 | $16,400 | 10,000 (Direct) |
View |
2021-12-13 Purchase |
2021-12-15 4:45 pm |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
21,000 | $5.4794 | $115,067 | 99,662 (Indirect Direct) |
View |
2021-12-10 Purchase |
2021-12-14 5:32 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $5.9752 | $5,975 | 2,408,719 (Indirect Direct) |
View |
2021-12-03 Purchase |
2021-12-07 4:23 pm |
Better Therapeutics Inc. | BTTX | Granger Elder Director |
1,000 | $6.66 | $6,660 | 1,000 (Direct) |
View |
2021-12-02 Purchase |
2021-12-06 5:34 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $6.633 | $6,633 | 2,407,719 (Indirect Direct) |
View |
2021-11-29 Purchase |
2021-12-01 4:42 pm |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
17,000 | $6.96 | $118,320 | 78,662 (Indirect Direct) |
View |
2021-04-30 Purchase |
2021-11-01 8:55 pm |
Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust See Remarks 10% Owner |
251,536 | $9.9884 | $2,512,432 | 10,909,873 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-09 Option Award |
2022-06-10 4:43 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | Granger Elder Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:42 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:42 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | Liu Suying Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:40 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | LAVIZZO-MOUREY RISA J Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:39 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | Carmona Richard H Director |
15,000 | $0 | 15,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:39 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
15,000 | $0 | 179,662 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:39 pm |
N/A 2032-06-08 |
Better Therapeutics Inc. | BTTX | PERRY DAVID P See Remarks 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2022-05-27 Exercise |
2022-06-01 4:47 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | Zamirowski Justin Chief Commercial Officer |
1,677 | $0.5 | 80,539 (Direct) |
View |
2022-05-27 Exercise |
2022-06-01 4:47 pm |
N/A 2030-08-13 |
Better Therapeutics Inc. | BTTX | Zamirowski Justin Chief Commercial Officer |
1,677 | $0 | 80,539 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 5:12 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | Zamirowski Justin Chief Commercial Officer |
35,236 | $0.5 | 80,539 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 5:12 pm |
N/A 2030-08-13 |
Better Therapeutics Inc. | BTTX | Zamirowski Justin Chief Commercial Officer |
35,236 | $0 | 80,539 (Direct) |
View |
2022-04-01 Option Award |
2022-04-04 4:45 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Wynholds Kristin Chief Product Officer |
116,700 | $0 | 116,700 (Direct) |
View |
2022-04-01 Option Award |
2022-04-04 4:45 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Zamirowski Justin Chief Commercial Officer |
86,800 | $0 | 86,800 (Direct) |
View |
2022-04-01 Option Award |
2022-04-04 4:43 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Berman Mark A. Chief Medical Officer |
116,700 | $0 | 116,700 (Direct) |
View |
2022-04-01 Option Award |
2022-04-04 4:28 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Heinen Mark See Remarks |
32,800 | $0 | 47,800 (Direct) |
View |
2022-04-01 Option Award |
2022-04-04 4:27 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
235,000 | $0 | 2,647,969 (Direct) |
View |
2021-11-10 Option Award |
2021-11-15 5:17 pm |
N/A 2031-11-09 |
Better Therapeutics Inc. | BTTX | Granger Elder Director |
28,300 | $0 | 28,300 (Direct) |
View |
2021-10-28 Option Award |
2021-11-01 9:02 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | Carmona Richard H Director |
181,919 | $0 | 181,919 (Direct) |
View |
2021-10-28 Option Award |
2021-11-01 8:59 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | Liu Suying Director |
28,300 | $0 | 1,430,800 (Direct) |
View |
2021-10-28 Other |
2021-11-01 8:59 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | Liu Suying Director |
1,545,000 | $0 | 1,430,800 (Indirect) |
View |
2021-10-28 Option Award |
2021-11-01 8:57 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | Parker Geoffrey M. Director |
61,633 | $0 | 61,633 (Direct) |
View |
2021-10-28 Option Award |
2021-11-01 8:56 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | Armanino Andrew J. Director |
89,962 | $0 | 103,296 (Direct) |
View |
2021-10-28 Option Award |
2021-11-01 8:55 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust See Remarks 10% Owner |
10,506,801 | $0 | 10,909,873 (Direct) |
View |
2021-10-28 Option Award |
2021-11-01 8:55 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | PERRY DAVID P David P. Perry 2015 Trust See Remarks 10% Owner |
100,000 | $10 | 10,909,873 (Indirect) |
View |
2021-10-28 Option Award |
2021-11-01 8:55 pm |
N/A 2031-10-27 |
Better Therapeutics Inc. | BTTX | LAVIZZO-MOUREY RISA J Director |
28,300 | $0 | 28,300 (Direct) |
View |
Ownership |
2021-11-01 8:55 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
0 | $0 | 2,643,600 (Indirect) |
View |